Findings

What do systematic reviews say?

266 questions · 274 findings · 25 reviews · Movement Disorders

Sort:Best matchNewestHighest certainty Download CSV

No studies found 13 · 4.7%GRADE not reported 7 · 2.6%Very low 66 · 24.1%Low 66 · 24.1%Moderate 87 · 31.8%High 35 · 12.8%

Dopamine agonist vs placebo

Subjective sleep quality or quantity · patients with restless legs syndrome according to IRLSSG, 18 years or older

1 finding from 1 review

Dopamine agonists for the treatment of restless legs syndrome 2011 · Cochrane Headline outcomes only
no estimate extracted
22 studies · 4592 participants
High

Dopamine agonist vs placebo

QoL · patients with restless legs syndrome according to IRLSSG, 18 years or older

1 finding from 1 review

Dopamine agonists for the treatment of restless legs syndrome 2011 · Cochrane Headline outcomes only
no estimate extracted
17 studies · 4312 participants
Moderate

Dopamine agonist vs levodopa

IRLS · patients with restless legs syndrome

1 finding from 1 review

Dopamine agonists for the treatment of restless legs syndrome 2011 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 383 participants
Moderate

Dopamine agonist vs levodopa

Periodic limb movements per hour of time in bed · patients with restless legs syndrome

1 finding from 1 review

Dopamine agonists for the treatment of restless legs syndrome 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Low

BoNT‐A vs placebo/no treatment

Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Moderate

BoNT‐A/OT vs OT only

Quality of movement (18 mths ‐ 8yrs) Quality of Upper Extremity Skills Test. Scale from: 0 to 100. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 84 participants
High

BoNT‐A/OT vs OT only

Quality of movement (5 yrs ‐ 15yrs) The Melbourne Assessment. Scale from: 0 to 100. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 69 participants
High

BoNT‐A/OT vs OT only

Goal attainment Goal Attainment Scaling3. Scale from: 20 to 80. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 152 participants
High

BoNT‐A/OT vs OT only

Occupational performance ‐ performance Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 109 participants
High

BoNT‐A/OT vs OT only

Occupational performance ‐ satisfaction Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 109 participants
High

BoNT‐A/OT vs BoNT‐A only

Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Wrist flexor spasticity modified Tardieu scale. Scale from: 0 to 90. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
High

BoNT‐A/OT vs BoNT‐A only

Quality of movement (18 mths ‐ 8yrs) Quality of Upper Extremity Skills Test. Scale from: 0 to 100. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 14 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Quality of movement (5 yrs ‐ 15yrs) The Melbourne Assessment. Scale from: 0 to 100. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 22 participants
High

BoNT‐A/OT vs BoNT‐A only

Goal attainment Goal Attainment Scaling3. Scale from: 20 to 80. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
High

BoNT‐A vs placebo/no treatment

Wrist flexor spasticity modified Tardieu scale. Scale from: 0 to 90. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Occupational performance ‐ performance Canadian Occupational Performance Measure. Scale from: 0 to 10. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Occupational performance ‐ satisfaction Canadian Occupational Performance Measure. Scale from: 0 to 10. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

BoNT‐A/OT vs placebo/no treatment

Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 35 participants
Moderate

BoNT‐A/OT vs placebo/no treatment

Wrist flexor spasticity modified Tardieu scale. Scale from: 0 to 90. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 35 participants
High